Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunosuppressive treatment im multiple sclerosis].

J Mertin

    Fortschritte Der Medizin
    |October 2, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Immunosuppression shows promise in treating multiple sclerosis (MS), improving the condition for about half of patients. Future research aims to enhance these treatments and explore targeted immunotherapies for MS.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2005
    Same author

    Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

    Journal of neurology·2004
    Same author

    The Trunk Impairment Scale: a new tool to measure motor impairment of the trunk after stroke.

    Clinical rehabilitation·2004
    Same author

    Rehabilitation in multiple sclerosis.

    Annals of neurology·1994
    Same author

    Overview of azathioprine treatment in multiple sclerosis.

    Lancet (London, England)·1991
    Same author

    [Rehabilitation in multiple sclerosis].

    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1991
    Same journal

    [More information--less pain. Procedure in pain following amputation of limbs. Brachial plexus injury and nerve root avulsion. Interview by Susanne Kammerer].

    Fortschritte der Medizin·1999
    Same journal

    [Galenic alternatives to unstable tocopherol acetate. "Smeared" or cheated?--Vitamin E in facial ointments].

    Fortschritte der Medizin·1999
    Same journal

    [Gene diagnosis in the hand of the physician].

    Fortschritte der Medizin·1999
    Same journal

    [Is non-toxic cancer therapy through biotechnology a possibility?].

    Fortschritte der Medizin·1999
    Same journal

    [Smoking withdrawal in practice and clinic].

    Fortschritte der Medizin·1999
    Same journal

    [The future of pancreas diagnosis. An exclusive training service of the Gastro-Ligue for dermatologists].

    Fortschritte der Medizin·1999
    See all related articles

    Area of Science:

    • Neuroimmunology
    • Clinical immunology
    • Pharmacology

    Context:

    • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
    • Current treatment strategies for MS often involve broad immunosuppression.
    • Uncontrolled trials suggested potential benefits of immunosuppression in MS.

    Purpose:

    • To evaluate the efficacy of immunosuppression in managing the clinical course of multiple sclerosis.
    • To confirm initial findings from uncontrolled trials with a double-blind, controlled study.
    • To identify future directions for improving immunosuppressive therapies for MS.

    Summary:

    • Uncontrolled studies indicated that immunosuppression benefits approximately 50% of multiple sclerosis patients.
    • A recent double-blind, controlled study corroborated these positive findings.

    Related Experiment Videos

  • The efficacy of conventional immunosuppressive agents in MS treatment requires further enhancement.

    • Impact:

    • Confirms the therapeutic potential of immunosuppression in multiple sclerosis management.
    • Highlights the need for more effective immunosuppressive strategies in MS.
    • Suggests that advancements in immunology and understanding MS etiology could lead to specific immunotherapies.